Benefits
Diabetic Peripheral Neuropathy
None of the four studies cited on this page looked at nerve symptoms or any other health outcome. They measured blood levels only. The human trials in people with diabetic nerve pain that are often quoted for lipoic acid used racemic ALA (the 50/50 mixture), not isolated R-ALA, and they are not cited here; our alpha-lipoic acid page covers them. R-ALA is the naturally occurring half of that mixture, but nothing cited on this page shows it helps nerve symptoms.
Antioxidant Activity (Both Water and Lipid Soluble)
Lipoic acid dissolves in both water and fat, and in laboratory work it can help regenerate other antioxidants such as vitamin C, vitamin E and glutathione. In people, the only antioxidant-related measurement in the studies cited here was plasma glutathione in a pilot absorption study of six younger and six older adults. That is one blood marker in a very small single-dose study, not evidence of a health benefit.
Insulin Sensitivity / Blood Sugar
This page cites no trial of blood sugar control. One cited absorption study, in six healthy volunteers, also recorded plasma glucose after a single dose, which is a side measurement rather than a test of blood sugar benefit. Lipoic acid has been studied for glucose control in people with type 2 diabetes, but those studies used racemic ALA and are covered on our alpha-lipoic acid page. Nothing here supports using R-ALA in place of prescribed diabetes treatment.
Mitochondrial Function
Lipoic acid is made in the body and acts as a helper molecule for enzymes that turn food into energy inside cells. That is established biochemistry, but none of the studies cited on this page measured energy, fatigue or exercise capacity in people.
Metal Binding (Laboratory Chemistry Only)
In test-tube chemistry, lipoic acid can bind metals such as mercury, arsenic and cadmium. No study cited on this page measured heavy metals in any person. Chelation for suspected heavy metal poisoning is a medical procedure that requires diagnosis and supervision by a doctor, and unsupervised chelation has caused serious harm. Do not use R-lipoic acid to try to remove metals from your body.
Mechanism of action
Endogenous Mitochondrial Cofactor
R-ALA is the naturally-occurring enantiomer in mitochondria — bound to specific lysine residues on enzymes (lipoyllysine). Cofactor for pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, branched-chain ketoacid dehydrogenase, glycine cleavage system.
R-ALA vs S-ALA Activity
R-form is biologically active; S-form has minimal direct biological activity. A racemic (50/50) product therefore delivers about half its milligrams as the R form. Whether that means a stronger effect in people has not been tested in any study cited here; the cited research compared blood levels only, not results.
Glutathione Recycling
In laboratory work, lipoic acid converts used-up (oxidized) glutathione back to its active form, which is why it is described as helping the body's own antioxidant system. This is mechanism, not a measured benefit in people.
AMPK Activation
In laboratory studies lipoic acid activates an enzyme called AMPK, which is involved in how cells take up and burn fuel. This is a proposed mechanism from cell and animal work, not something measured in the human studies cited on this page.
Clinical trials
A pharmacokinetic study (PMID 18069903) giving a single 600 mg dose of sodium R-lipoate and measuring how much appeared in the blood over time (peak level, total exposure, time to peak, half-life).
12 healthy adults.
The stabilized sodium salt reached measurable levels in the blood after a single dose. Key limitation: this study measured blood concentrations only. It did not measure nerve symptoms, blood sugar or any other health outcome, and there was no test of benefit against placebo. The neuropathy trials often quoted for lipoic acid used the racemic form and are not cited on this page.
A small bioavailability study (PMID 27314343) comparing an R-lipoic acid and gamma-cyclodextrin complex with plain R-lipoic acid, measuring blood levels of lipoic acid and plasma glucose after dosing.
6 healthy volunteers.
The cyclodextrin complex produced higher blood levels of R-lipoic acid than the plain form. Limitations: only six people, a single-dose absorption design, and no clinical endpoint such as HbA1c or long-term blood sugar control. Plasma glucose was an incidental blood measurement, not evidence that the supplement improves blood sugar.